NovaBay Pharmaceuticals, Inc. Current Revenue (Deferred)

Current Revenue (Deferred) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Revenue (Deferred) growth rates and interactive chart.


Highlights and Quick Summary

  • Current Revenue (Deferred) for the quarter ending June 30, 2020 was $547 Thousand (a -2.15% decrease compared to previous quarter)
  • Year-over-year quarterly Current Revenue (Deferred) increased by 782.26%
  • Annual Current Revenue (Deferred) for 2018 was $41 Thousand (a -98.56% decrease from previous year)
  • Annual Current Revenue (Deferred) for 2017 was $2.84 Million (a 52.66% increase from previous year)
  • Annual Current Revenue (Deferred) for 2016 was $1.86 Million (a 994.71% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Revenue (Deferred) of NovaBay Pharmaceuticals, Inc.

Most recent Current Revenue (Deferred)of NBY including historical data for past 10 years.

Interactive Chart of Current Revenue (Deferred) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $0.55 $0.56
2018 $0.04 $0.06 $0.06 $0.06 $0.04
2017 $2.84 $2.49 $2.17 $1.67 $2.84
2016 $1.86 $1.46 $1.59 $0.19 $1.86
2015 $0.17 $0.38 $0.22 $0.43 $0.17
2014 $0.43 $0.26 $0.2 $0.2 $0.43
2013 $0.34 $0.21 $0.47 $0.76 $0.34
2012 $1.22 $1.41 $1.54 $1.33 $1.22
2011 $1.31 $1.31

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology